Droia Ventures

Foundation date

31/08/2012

Sector

#Investor

Subsector

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. We invest in novel science and innovative approaches to bring promising drug candidates to patients, and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. We have an in-house team of experts and drug development professionals who follow our companies closely and provide hands-on support.

Droia invests in early financing rounds and also incubates new companies. Operating from Luxembourg and Belgium, Droia invests globally.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    14 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    1 day ago

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024